153 related articles for article (PubMed ID: 24163506)
1. Inflammatory mediators of angiogenesis.
Szewczyk G; Rak J; Ruth JH
Mediators Inflamm; 2013; 2013():610543. PubMed ID: 24163506
[No Abstract] [Full Text] [Related]
2. Tumor suppression through angiogenesis inhibition.
Arsham AM; Simon MC
Methods Mol Biol; 2003; 223():249-70. PubMed ID: 12777736
[No Abstract] [Full Text] [Related]
3. Angiogenesis in rheumatoid arthritis.
Szekanecz Z; Besenyei T; Paragh G; Koch AE
Autoimmunity; 2009 Nov; 42(7):563-73. PubMed ID: 19863375
[TBL] [Abstract][Full Text] [Related]
4. Boswellic acid inhibits inflammatory angiogenesis in a murine sponge model.
Saraswati S; Pandey M; Mathur R; Agrawal SS
Microvasc Res; 2011 Nov; 82(3):263-8. PubMed ID: 21864545
[TBL] [Abstract][Full Text] [Related]
5. Strychnine inhibits inflammatory angiogenesis in mice via down regulation of VEGF, TNF-α and TGF-β.
Saraswati S; Agarwal SS
Microvasc Res; 2013 May; 87():7-13. PubMed ID: 23395890
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor (VEGF), mast cells and inflammation.
Shaik-Dasthagirisaheb YB; Varvara G; Murmura G; Saggini A; Potalivo G; Caraffa A; Antinolfi P; Tete' S; Tripodi D; Conti F; Cianchetti E; Toniato E; Rosati M; Conti P; Speranza L; Pantalone A; Saggini R; Theoharides TC; Pandolfi F
Int J Immunopathol Pharmacol; 2013; 26(2):327-35. PubMed ID: 23755748
[TBL] [Abstract][Full Text] [Related]
7. Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature.
Rutella S; Vetrano S; Correale C; Graziani C; Sturm A; Spinelli A; De Cristofaro R; Repici A; Malesci A; Danese S
J Cell Mol Med; 2011 Mar; 15(3):625-34. PubMed ID: 20158572
[TBL] [Abstract][Full Text] [Related]
8. Natural honey: a new and potent anti-angiogenic agent in the air-pouch model of inflammation.
Eteraf-Oskouei T; Najafi M; Gharehbagheri A
Drug Res (Stuttg); 2014 Oct; 64(10):530-6. PubMed ID: 24357137
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases.
Fallah A; Sadeghinia A; Kahroba H; Samadi A; Heidari HR; Bradaran B; Zeinali S; Molavi O
Biomed Pharmacother; 2019 Feb; 110():775-785. PubMed ID: 30554116
[TBL] [Abstract][Full Text] [Related]
10. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.
Bunone G; Vigneri P; Mariani L; Butó S; Collini P; Pilotti S; Pierotti MA; Bongarzone I
Am J Pathol; 1999 Dec; 155(6):1967-76. PubMed ID: 10595926
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondins 1 and 2 function as inhibitors of angiogenesis.
Armstrong LC; Bornstein P
Matrix Biol; 2003 Mar; 22(1):63-71. PubMed ID: 12714043
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Antiangiogenic Efficacy of Emilia sonchifolia (L.) DC on Tumor-Specific Neovessel Formation by Regulating MMPs, VEGF, and Proinflammatory Cytokines.
Gilcy GK; Kuttan G
Integr Cancer Ther; 2016 Dec; 15(4):NP1-NP12. PubMed ID: 27146127
[TBL] [Abstract][Full Text] [Related]
13. Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in experimental glomerulonephritis in mice.
Daniel C; Amann K; Hohenstein B; Bornstein P; Hugo C
J Am Soc Nephrol; 2007 Mar; 18(3):788-98. PubMed ID: 17287428
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of atractylenolide I on angiogenesis in chronic inflammation in vivo and in vitro.
Wang C; Duan H; He L
Eur J Pharmacol; 2009 Jun; 612(1-3):143-52. PubMed ID: 19356732
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis.
Streit M; Riccardi L; Velasco P; Brown LF; Hawighorst T; Bornstein P; Detmar M
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14888-93. PubMed ID: 10611308
[TBL] [Abstract][Full Text] [Related]
16. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
[TBL] [Abstract][Full Text] [Related]
17. The role of CX₃CL1/CX₃CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome.
Zhang J; Yang W; Luo B; Hu B; Maheshwari A; Fallon MB
J Hepatol; 2012 Oct; 57(4):752-8. PubMed ID: 22659346
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of inflammatory angiogenesis by distant subcutaneous tumor in mice.
Belo AV; Barcelos LS; Ferreira MA; Teixeira MM; Andrade SP
Life Sci; 2004 Apr; 74(23):2827-37. PubMed ID: 15050421
[TBL] [Abstract][Full Text] [Related]
19. CD36-TSP-HRGP interactions in the regulation of angiogenesis.
Silverstein RL; Febbraio M
Curr Pharm Des; 2007; 13(35):3559-67. PubMed ID: 18220792
[TBL] [Abstract][Full Text] [Related]
20. Vernolide-A inhibits tumour specific angiogenesis by regulating proinflammatory cytokines, VEGF, MMPs and TIMP.
Pratheeshkumar P; Kuttan G
Eur J Pharmacol; 2011 Apr; 656(1-3):10-8. PubMed ID: 21256125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
